Having demonstrated the role of obesity in modulating the subsequent type 2 inflammation, we next determined if PA promotes pre-existing type 2 inflammation induced by IL-13 or HDM. The gene discussed is IL13; the disease is obesity due to melanocortin 4 receptor deficiency.